| # | Drug | Count |
|---|---|---|
| 0 | DARBEPOETIN ALFA | 12 |
| 1 | ACETAMINOPHEN | 4 |
| 2 | CALCIUM | 4 |
| 3 | VENLAFAXINE | 4 |
| 4 | VENLAFAXINE HYDROCHLORIDE | 4 |
| 5 | ALBUTEROL SULFATE | 3 |
| 6 | ASPIRIN | 3 |
| 7 | ASPIRIN 325 MG | 3 |
| 8 | ASPIRIN 81 MG | 3 |
| 9 | DENOSUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL, UNSPECIFIED | 1 | 0.0100 |
| 1 | BRENSOCATIB | 1 | 0.0004 |
| 2 | METAXALONE | 1 | 0.0003 |
| 3 | CARBIDOPA LEVODOPA | 1 | 0.0003 |
| 4 | LARONIDASE | 1 | 0.0002 |
| 5 | ENTACAPONE | 1 | 0.0002 |
| 6 | PENTOXIFYLLINE | 1 | 0.0002 |
| 7 | DARBEPOETIN ALFA | 12 | 0.0002 |
| 8 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 9 | RASAGILINE MESYLATE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 2 | Erythropoiesis-stimulating Agent [EPC] | 12 | 0.0002 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |